Valuation : Atrion Corporation

Market Cap 809M 697M 655M 599M 1.12B 76.42B 1.12B 7.74B 3B 39.21B 3.04B 2.97B 126B P/E 2022
28.6x
P/E 2023 34.4x
Enterprise Value 803M 691M 650M 594M 1.11B 75.86B 1.11B 7.69B 2.98B 38.92B 3.02B 2.95B 125B EV / Sales 2022
5.27x
EV / Sales 2023 3.9x
Free-Float
50.88%
Yield 2022
1.47%
Yield 2023 2.3%
3 years 274.98
Extreme 274.98
503.24
5 years 274.98
Extreme 274.98
805.62
10 years 274.98
Extreme 274.98
948.03
Manager TitleAgeSince
Corporate Secretary 53 21/08/2024
Director TitleAgeSince
Director/Board Member 53 21/08/2024
Date Insider Type Main position Quantity % Market Cap. Importance
21/8/24 Issuer sale

Director

2,991 0.1699%
21/8/24 Issuer sale

Chief Executive Officer

98,614 5.6032%
21/8/24 Issuer sale

Director

499 0.0284%
Change 5-day change 1-year change 3-year change Capi.($)
+0.06%-.--%-.--%-2.79% 809M
-0.42%-3.68%-18.51%+6.67% 187B
+1.15%+3.22%+1.37%+16.68% 120B
-1.86%+2.77%+13.15%+89.47% 63.15B
-0.33%-2.20%+15.92%+49.39% 51.75B
-1.54%-2.52%-3.98%-30.72% 50.32B
-2.02%-3.22%+9.18%-17.76% 33.17B
0.00%+3.71% - - 32.1B
-0.81%+0.74%+35.59%-16.03% 23.93B
-1.81%-5.09%-10.14%+8.89% 22.99B
Average -0.76%-0.43%+4.73%+11.53% 58.61B
Weighted average by Cap. -0.48%-0.64%-1.68%+16.51%

Financials

2022 2023
Net sales 184M 158M 149M 136M 254M 17.33B 255M 1.76B 681M 8.89B 689M 674M 28.64B 169M 146M 137M 125M 234M 15.99B 235M 1.62B 629M 8.2B 636M 622M 26.42B
Net income 35.01M 30.12M 28.34M 25.89M 48.43M 3.31B 48.57M 335M 130M 1.7B 131M 129M 5.46B 19.41M 16.7M 15.72M 14.36M 26.86M 1.83B 26.93M 186M 72.06M 940M 72.89M 71.3M 3.03B
Net Debt -25.21M -21.69M -20.41M -18.65M -34.88M -2.38B -34.98M -241M -93.59M -1.22B -94.67M -92.61M -3.93B -6.02M -5.18M -4.87M -4.45M -8.32M -568M -8.35M -57.55M -22.33M -291M -22.59M -22.1M -939M
Logo Atrion Corporation
Atrion Corporation develops and manufactures products, primarily for medical applications. The Company's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. It has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The Company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.
Employees
712
  1. Stock Market
  2. Stocks
  3. ATRI Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!